The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Thin Film Drug Manufacturing Market In 2026 And What Value Is Projected For 2030?
The thin film drug manufacturing market has experienced substantial growth in recent years. This market is projected to expand from $8.71 billion in 2025 to $9.51 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.2%. Historically, this growth has been fueled by factors such as the challenges in swallowing traditional tablets, an increasing focus on patient compliance, the early adoption of oral dissolving technologies, a rising demand for rapid onset therapies, and the expansion of hospital pharmacy distribution channels.
The thin film drug manufacturing market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $13.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. Several factors will contribute to this growth during the forecast period, including progress in thin film formulation technologies, an increase in neurological disorders, the broadening of e-commerce pharmaceutical distribution channels, increased funding for innovative drug delivery methods, and a rise in regulatory clearances for thin film medications. Key trends identified for the forecast period encompass a greater acceptance of oral thin films for quick drug delivery, a heightened need for dosage forms that are convenient for patients, an expanded application of thin films in the treatment of neurological and CNS disorders, the development of taste-masked and orodispersible film technologies, and an increased utilization of thin films in managing migraine and opioid dependence.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19730&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Thin Film Drug Manufacturing Market?
The expanding global senior demographic is anticipated to stimulate the advancement of the thin-film drug manufacturing market in the future. This growth in the worldwide elderly populace stems from factors such as longer life expectancies, progress in medicine, better nutrition and healthcare provisions, and shifts in both family dynamics and societal standards. Thin film drug manufacturing addresses the demands of the increasing senior demographic through benefits like enhanced medication compliance, user-friendliness, accurate dosage regulation, quick dissolving properties, and greater stability. These combined features facilitate superior management of persistent health issues and foster overall well-being for older individuals. For example, data from January 2024, provided by the Population Reference Bureau, a US-based nonprofit organization, forecasts that the population of Americans aged 65 and above will rise from 58 million in 2022 to 82 million by 2050. Consequently, the expanding global elderly demographic is a primary impetus for the thin film drug manufacturing market.
What Are The Key Segments Of The Thin Film Drug Manufacturing Market?
The thin film drug manufacturing market covered in this report is segmented –
1) By Type: Oral Thin Film, Transdermal Film, Other Types
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea And Vomiting, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-Commerce
Subsegments:
1) By Oral Thin Film: SubLingual Films, Buccal Films, Orodispersible Films, Taste-Masked Oral Films
2) By Transdermal Film: Adhesive Transdermal Films, Matrix Transdermal Films, Reservoir Transdermal Films, Drug-Eluting Transdermal Films
3) By Other Types: Topical Films, Ophthalmic Films, Intranasal Films, Veterinary Thin Films
What Key Trends Are Influencing The Development Of The Thin Film Drug Manufacturing Market?
Leading companies in the thin film drug manufacturing market are prioritizing the development of innovative products, such as oral thin film technologies, to boost patient compliance and convenience. These oral thin film technologies involve creating films that dissolve rapidly, delivering medication through the mouth’s mucous membranes for quick absorption. Such films provide a convenient, effective, and user-friendly alternative to traditional oral dosage forms like tablets and capsules. For example, in April 2023, IntelGenx Corporation, a Canada-based pharmaceutical company, announced the Food and Drug Administration (FDA) approval of RIZAFILM for the treatment of acute migraine. This new formulation allows for rapid dissolution and absorption, potentially offering faster relief for migraines compared to traditional tablets. This innovation improves bioavailability and presents a more convenient, user-friendly option, thereby enhancing patient compliance. Ultimately, thin film technology improves patient compliance and ease of use, making it a more accessible alternative for managing acute migraine attacks.
Who Are The Leading Companies Operating In The Thin Film Drug Manufacturing Market?
Major companies operating in the thin film drug manufacturing market are Novartis AG, Merck KGaA, Dr. Reddy’s Laboratories, Indivior PLC, LTS Lohmann Therapie-Systeme AG, Aquestive Therapeutics, Zim Laboratories Ltd, Tapemark, AdhexPharma, MonoSol Rx, Aavishkar Oral Strips Pvt Ltd., APR Applied Pharma Research SA, Cynapsus Therapeutics Inc., Jurata Thin Film Inc., Nova Thin Film Pharmaceuticals LLC, Vektor Pharma TF GmbH, TFF Pharmaceuticals Inc., NAL Pharma, IntelGenx Corp, D.K. Livkon Healthcare Pvt Ltd.
Read the full thin film drug manufacturing market report here:
https://www.thebusinessresearchcompany.com/report/thin-film-drug-manufacturing-global-market-report
What Are The Leading Geographic Regions In The Thin Film Drug Manufacturing Market?
North America was the largest region in the thin film drug manufacturing market in 2025. The regions covered in the thin film drug manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Thin Film Drug Manufacturing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19730&type=smp
Browse Through More Reports Similar to the Global Thin Film Drug Manufacturing Market 2026, By The Business Research Company
Psychedelic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report
Drug Screening Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report
Drug Discovery Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model